ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

May 24, 1991

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

Niccotine Reports As Aiding Metastasis

August 22, 1986

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002